Physician profile
Shannon Lillard
NPI 1063185668
$748.49
in general payments reported to CMS, 2019-2025
12 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.23 · 2023: $130 · 2024: $443 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $302.15 | 2023-2024 | |
| Kerecis Limited | $198.93 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Melinta Therapeutics, LLC | $47.17 | 2024 | Kimyrsa, Orbactiv |
| Smith+Nephew, INC. | $35.51 | 2023-2025 | Stravix |
| Tactile Systems Technology INC | $29.79 | 2024 | Entre Plus, Flexitouch Plus |
| Nestle Healthcare Nutrition INC. | $27.23 | 2021 | |
| Coloplast Corp | $19.98 | 2025 | |
| Molnlycke Health Care US, LLC | $19.83 | 2023 | Mepitel One, Exufiber Ag+, Mepilex Transfer Ag |
| Hydrofera LLC | $19.15 | 2023 | Hydrofera Blue |
| Solventum Corporation | $17.74 | 2024 | Promogran Prisma, 3m Cavilon, V.A.C. Dermatac |
| Ironshore Pharmaceuticals INC. | $16.56 | 2023 | Jornay Pm |
| Davol INC. | $14.45 | 2023 | Arista Ah Flexitip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Lillard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.